Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

5.19
Delayed Data
As of Oct 20
 +0.22 / +4.43%
Today’s Change
1.17
Today|||52-Week Range
6.55
+103.53%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sherman Michael A
President, Chief Executive & Financial Officer
Buy5/31/201744,285$2.10$93.0K+103.53%
Leamon Christopher P
Vice President-Research
Sale12/30/201623,244$2.55$59.3K+103.53%
Leamon Christopher P
Vice President-Research
Buy12/30/201626,178$2.10$55.0K+103.53%
Low Philip S
Chief Scientific Officer
Buy11/15/201615,706$2.10$33.0K+76.53%
Sherman Michael A
President, Chief Executive & Financial Officer
Sale2/04/20173,092$2.18$6.7K+138.07%
Low Philip S
Chief Scientific Officer
Sale2/04/20171,888$2.18$4.1K+138.07%
Leamon Christopher P
Vice President-Research
Sale2/04/20171,888$2.18$4.1K+138.07%
Brinkley Michael A
Vice President-Quality
Sale2/04/20171,079$2.18$2.4K+138.07%
Armour Alison
Chief Medical Officer
Sale2/04/2017935$2.18$2.0K+138.07%
Low Philip S
Chief Scientific Officer
Sale2/06/2017694$2.18$1.5K+138.07%
Page of 4